e.g. Tata motors, Reliance MF, 500570

SMS Pharmaceuticals Ltd. - Research Center

532815 SMSPHARMA Group (B) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income
Operating income 709.26 522.05 519.87 563.18 411.95
Expenses
Material consumed 430.70 341.38 282.10 345.37 251.38
Manufacturing expenses 66.79 51.55 48.23 34.02 28.62
Personnel expenses 64.15 55.04 51.02 41.17 39.35
Selling expenses - - - - -
Adminstrative expenses 30.79 19.37 24.03 21.50 12.68
Expenses capitalised - - - - -
Cost of sales 592.42 467.35 405.39 442.07 332.03
Operating profit 116.84 54.70 114.48 121.11 79.92
Other recurring income 4.46 4.89 5.20 3.45 5.11
Adjusted PBDIT 121.30 59.59 119.68 124.56 85.03
Financial expenses 23.46 21.92 18.88 11.16 12.21
Depreciation 31.52 32.13 32.15 22.28 22.07
Other write offs - - - - -
Adjusted PBT 66.33 5.55 68.65 91.12 50.76
Tax charges 16.91 1.47 0.62 30.16 18.07
Adjusted PAT 49.42 4.08 68.04 60.96 32.69
Non recurring items 0.05 -0.21 0.04 -0.16 -0.09
Other non cash adjustments - - - - -
Reported net profit 49.48 3.88 68.08 60.80 32.60
Earnigs before appropriation 371.70 324.76 333.42 275.35 229.65
Equity dividend 2.54 2.54 2.54 - 5.10
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 369.16 322.22 330.88 275.35 224.55
Close
Add SMS Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add SMS Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close